EsophyX System - Cutting Edge Long Term Acid Reflux Treatment

Approximately 14 million Americans experience symptoms of GERD, including heartburn and esophageal inflammation, on a daily basis. Most manage their acid reflux disease with medications such as H2 blockers and proton pump inhibitors (PPIs). Since pharmacological therapy does not treat the underlying root causes of acid reflux, the deteriorated anatomy of the antireflux barrier, life-long medication therapy is required. Although acid reflux surgery is highly effective, it is also very invasive, despite the laparoscopic surgical approach. For this reason, less than 1% of the patients choose acid reflux surgery to repair the anatomical defect(s) that cause GERD.

The GERD program of Long Island Minimally Invasive Surgery, one of New York’s most reputable programs, is located on the North Shore of Long Island. It is one of the first centers in the entire United States trained to perform the new Esophyx - Transoral Incisionless Fundoplication (TIF). This is one of the premiere centers in the United States to undergo cutting edge endoscopic procedures for acid reflux treatment.

Our spacious facility is staffed with two full time surgeons - Shawn Garber, MD FACS and Spencer Holover, MD; each with extensive experience in laparoscopic surgery, and both recognized as leaders in the field of endoluminal and minimally invasive surgery, particularly in the New York area.

 

Shawn M. Garber M.D., F.A.C.S. Dr. Garber is the one of the first surgeons in the United States to perform the new Esophyx - transoral incisionless fundoplication. He has one of the most extensive experiences in the field of endoluminal and laparoscopic surgery in the entire New York area. Dr. Garber was the only surgeon on Long Island listed in New York Magazine as one of the top laparoscopic surgeons in the New York area and has been nominated by Castle Connelly as one the top surgeons in the US for the past 5 years. Click here to Read more